FATE THERAPEUTICS INC's ticker is FATE and the CUSIP is 31189P102. A total of 240 filers reported holding FATE THERAPEUTICS INC in Q3 2022. The put-call ratio across all filers is 0.68 and the average weighting 0.3%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q4 2022 | $3,842,898 | -42.8% | 380,862 | +27.0% | 0.02% | -50.0% |
Q3 2022 | $6,719,000 | +400.7% | 299,814 | +453.4% | 0.04% | +450.0% |
Q2 2022 | $1,342,000 | +351.9% | 54,175 | +606.8% | 0.01% | +700.0% |
Q1 2022 | $297,000 | -95.2% | 7,665 | -89.2% | 0.00% | -96.8% |
Q2 2021 | $6,178,000 | +16.7% | 71,184 | +10.9% | 0.03% | +6.9% |
Q1 2021 | $5,292,000 | +77.6% | 64,185 | +95.8% | 0.03% | +61.1% |
Q4 2020 | $2,980,000 | +934.7% | 32,775 | +355.0% | 0.02% | +800.0% |
Q3 2020 | $288,000 | +62.7% | 7,204 | -75.1% | 0.00% | +100.0% |
Q4 2017 | $177,000 | -31.1% | 28,900 | -55.5% | 0.00% | -50.0% |
Q3 2017 | $257,000 | +24.8% | 65,000 | +2.4% | 0.00% | +100.0% |
Q2 2017 | $206,000 | +9.6% | 63,500 | +53.8% | 0.00% | 0.0% |
Q1 2017 | $188,000 | – | 41,300 | – | 0.00% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Polaris Venture Management Co. V, L.L.C. | 569,889 | $46,987,000 | 60.92% |
Johnson & Johnson Innovation - JJDC, Inc. | 3,379,064 | $278,604,000 | 36.08% |
Darwin Global Management, Ltd. | 1,370,133 | $112,967,000 | 22.12% |
Redmile Group, LLC | 12,957,222 | $1,068,323,000 | 15.05% |
Copernicus Capital Management, LLC | 8,000 | $660,000 | 10.66% |
Casdin Capital, LLC | 3,400,000 | $280,330,000 | 8.35% |
Grosvenor Holdings, L.L.C. | 1,123,576 | $92,639,000 | 6.81% |
DAFNA Capital Management LLC | 314,360 | $25,919,000 | 6.15% |
Ally Bridge Group (NY) LLC | 270,000 | $22,262,000 | 4.27% |
Ghost Tree Capital, LLC | 185,000 | $15,253,000 | 3.58% |